Neuronetics (STIM) director Avinash Amin receives 30,000 RSU equity award

Rhea-AI Filing Summary

Neuronetics, Inc. director Avinash Amin reported an equity compensation grant in the form of 30,000 restricted stock units of common stock. The award vests on the earlier of May 28, 2027, a Board-approved separation of service, or a change in control, in each case subject to his continuous service. Each RSU converts into one share of common stock upon vesting. Following this grant, he holds 72,500 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Amin Avinash

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,000	$0.00	--

Holdings After Transaction: Common Stock — 72,500 shares (Direct, null)

Footnotes (1)

1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Key Figures

RSU grant size: 30,000 shares Holding after transaction: 72,500 shares Vesting date trigger: May 28, 2027 +1 more

4 metrics

RSU grant size 30,000 shares Restricted stock unit award to director Avinash Amin

Holding after transaction 72,500 shares Total direct common stock holdings after RSU grant

Vesting date trigger May 28, 2027 Latest vesting date for RSU award, subject to service

Transaction price per share $0.0000 per share Equity compensation grant, not open-market purchase

Key Terms

restricted stock unit ("RSU"), change in control, continuous service, contingent right

4 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") award that vests on the earlier of"

change in control financial

"or change in control of the Issuer, in each case subject to"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

continuous service financial

"subject to continuous service of the Reporting Person through such date"

contingent right financial

"Each RSU represents a contingent right to receive one share"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Amin Avinash

(Last) (First) (Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		A		30,000(1)	A	$0(2)	72,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.

2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	/s/ Francis Brown, as Attorney-in-Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Avinash Amin report for Neuronetics (STIM)?

Avinash Amin reported receiving 30,000 restricted stock units of Neuronetics common stock as an equity award. This is a compensation-related acquisition, not an open-market purchase or sale, and increases his direct holdings to 72,500 shares after the grant.

How do the 30,000 RSUs granted to Avinash Amin at Neuronetics (STIM) vest?

The 30,000 RSUs vest on the earlier of May 28, 2027, a Board-approved separation of service, or a change in control of Neuronetics. Vesting in each case is conditioned on Avinash Amin maintaining continuous service with the company through the applicable date.

What does each RSU granted to Avinash Amin at Neuronetics (STIM) represent?

Each restricted stock unit granted to Avinash Amin represents a contingent right to receive one share of Neuronetics common stock. The shares are delivered only when the RSUs vest under the specified conditions, rather than being issued immediately on the grant date.

How many Neuronetics (STIM) shares does Avinash Amin hold after this Form 4 filing?

After the reported RSU award, Avinash Amin holds 72,500 shares of Neuronetics common stock directly. This figure reflects his total direct ownership following the grant, as reported in the Form 4 transaction data for this filing.

Is Avinash Amin’s Neuronetics (STIM) RSU grant an open-market stock purchase?

No, the Form 4 classifies the 30,000-share award as a grant or other acquisition, not an open-market purchase. The transaction price per share is reported as $0.0000, consistent with equity compensation rather than a cash stock market transaction.